FGFR3 and chondroma: In conclusion, this first is the first study to demonstrate that loss of Fgfr3 leads to the downregulation of MAPK signaling and enhanced IHH expression, resulting in the formation of chondroma-like lesions, including enchondromas and osteochondromas.